Medical Devices Investors & VC Firms in China

96 firms in this list, with a median first check of $1M. 3 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AR Artesian JCJMMCAC42 people	88🔒	Australia	AU	Pre-Seed–Growth	—	+ Add to CRM
NO Novo Holdings KKBFHBKS35 people	88🔒	Copenhagen	DK	Pre-Seed–Late Stage	$1.1M – $54M	+ Add to CRM
AD Advent International RAFCJBJK36 people · Leads rounds	88🔒	Boston	US	Series A–Late Stage	$1.1B	+ Add to CRM
VI Vivo Capital DXDLEGFK11 people · Leads rounds	88🔒	Palo Alto	US	Seed–Late Stage	$10M – $50M	+ Add to CRM
LA LAV FCJLYS3 people	88🔒	Hong Kong	HK	Seed–Series C	$5M – $15M	+ Add to CRM
MI Mitsui Global Investment MMKNTTKF7 people	88🔒	Menlo Park	US	Seed–Late Stage	$500K – $10M	+ Add to CRM
K3 K3 Ventures MXNTATJR8 people	88🔒	—	SG	Seed–Series B	—	+ Add to CRM
SA Samsung Ventures DSJKJWMP22 people	88🔒	Menlo Park	US	Seed–Late Stage	—	+ Add to CRM
VE Vertex Ventures China CCJYTLWL6 people	88🔒	Singapore	SG	Pre-Seed–Late Stage	—	+ Add to CRM
ID IDG Capital DLGCJLJN11 people	88🔒	Hong Kong	US	Pre-Seed–Late Stage	$1M – $100M	+ Add to CRM
SH Shenzhen Capital Group DZSLXW3 people	88🔒	Shenzhen	CN	Seed–Growth	$1M – $3.5M	+ Add to CRM
GR Green Pine Capital Partners FLWL2 people	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
VE Vertex Ventures HC CBLHSCAC5 people	88🔒	San Francisco	US	Seed–Growth	$500K – $10M	+ Add to CRM
SB SBCVC ASCSKCMZ6 people	88🔒	Tortola	CN	Seed–Late Stage	—	+ Add to CRM
YU YuanBio Venture Capital JCGNJCLG7 people	88🔒	Suzhou	CN	Seed–Growth	—	+ Add to CRM
CH China Growth Capital HWHLJX3 people · Leads rounds	88🔒	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
DS dsm-firmenich Venturing SHAKADAM9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	—	SG	Seed–Series B	—	+ Add to CRM
JA JAFCO Group AFHNHTKA8 people	88🔒	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
CO Cowin Capital Group DDDDMDQP11 people	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
DA Darwin Venture Management SFYWEWKL8 people	88🔒	Taipei	TW	Seed–Late Stage	$1M – $5M	+ Add to CRM
FO Fortune Venture Capital BXGLHXKH11 people	88🔒	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
MP MPCi (formerly Matrix Partners China) BSDSDZEY11 people	88🔒	Singapore	CN	Seed–Growth	—	+ Add to CRM
VA VantagePoint Capital Partners JMAEBHNW8 people	88🔒	Santa Barbara	US	Seed–Late Stage	$2M – $100M	+ Add to CRM

Artesian

AustraliaPre-Seed–Growth

JCJMMCAC42 people

Novo Holdings

CopenhagenPre-Seed–Late Stage$1.1M – $54M

KKBFHBKS35 people

Advent International

BostonSeries A–Late Stage$1.1B

RAFCJBJK36 people

Vivo Capital

Palo AltoSeed–Late Stage$10M – $50M

DXDLEGFK11 people

LAV

Hong KongSeed–Series C$5M – $15M

FCJLYS3 people

Mitsui Global Investment

Menlo ParkSeed–Late Stage$500K – $10M

MMKNTTKF7 people

K3 Ventures

Seed–Series B

MXNTATJR8 people

Samsung Ventures

Menlo ParkSeed–Late Stage

DSJKJWMP22 people

Vertex Ventures China

SingaporePre-Seed–Late Stage

CCJYTLWL6 people

IDG Capital

Hong KongPre-Seed–Late Stage$1M – $100M

DLGCJLJN11 people

Shenzhen Capital Group

ShenzhenSeed–Growth$1M – $3.5M

DZSLXW3 people

Green Pine Capital Partners

ShenzhenSeed–Late Stage

FLWL2 people

Vertex Ventures HC

San FranciscoSeed–Growth$500K – $10M

CBLHSCAC5 people

SBCVC

TortolaSeed–Late Stage

ASCSKCMZ6 people

YuanBio Venture Capital

SuzhouSeed–Growth

JCGNJCLG7 people

China Growth Capital

BeijingPre-Seed–Series A

HWHLJX3 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

SHAKADAM9 people

EDB Investments

Seed–Series B

CKCLCGJO11 people

JAFCO Group

TokyoPre-Seed–Late Stage

AFHNHTKA8 people

Cowin Capital Group

ShenzhenSeed–Late Stage

DDDDMDQP11 people

Darwin Venture Management

TaipeiSeed–Late Stage$1M – $5M

SFYWEWKL8 people

Fortune Venture Capital

ShenzhenSeed–Late Stage

BXGLHXKH11 people

MPCi (formerly Matrix Partners China)

SingaporeSeed–Growth

BSDSDZEY11 people

VantagePoint Capital Partners

Santa BarbaraSeed–Late Stage$2M – $100M

JMAEBHNW8 people

Data sourced from public filings and firms' own websites — see our methodology.